Payment overview · 2025
General Payments
$332.29
9 reported records · 5 companies
Healthcare provider profile · identity verified
Chirag Patel, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · MERRILLVILLE, IN · NPI 1205981750
Verified facts
What the public records show
CMS Open Payments records show Chirag Patel, M.D. received $332.29 in general payments during 2025 across 9 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 37.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 19 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LUMIGAN as an associated drug or biological on 25016 records involving 7645 distinct recipient NPIs. Public Medicare Part D data also shows 33 claims for Lumigan by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Synthroid by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported VRAYLAR as an associated drug or biological on 377741 records involving 62704 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Vraylar by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 396 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 107 claims for Trulicity by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUEDEXTA as an associated drug or biological on 393 records involving 285 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Nuedexta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $125.00 | 37.6% | 1 | 2025 |
| Avadel CNS Pharmaceuticals, LLC | Unresolved — no canonical attribution shown | $118.09 | 35.5% | 4 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $36.47 | 11.0% | 2 | 2025 |
| Ipsen Biopharmaceuticals, Inc | Unresolved — no canonical attribution shown | $32.27 | 9.7% | 1 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $20.46 | 6.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $332.29 | 9 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $125.00 | 1 | 2025 |
Source payment records
|
|||||
| LUMRYZ Normalized: lumryz |
Drug | Avadel CNS Pharmaceuticals, LLC | $118.09 | 4 | 2025 |
Source payment records
|
|||||
| BOTOX Normalized: botox |
Biological | ABBVIE INC. | $36.47 | 2 | 2025 |
Source payment records
|
|||||
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $36.47 | 2 | 2025 |
Source payment records
|
|||||
| IQIRVO Normalized: iqirvo |
Drug | Ipsen Biopharmaceuticals, Inc | $32.27 | 1 | 2025 |
Source payment records
|
|||||
| AMYVID Normalized: amyvid |
Drug | Lilly USA, LLC | $20.46 | 1 | 2025 |
Source payment records
|
|||||
| KISUNLA Normalized: kisunla |
Drug | Lilly USA, LLC | $20.46 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
19 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LUMIGAN open payments reported associated product |
CMS Open Payments — General Payments 25016 supporting records · 7645 recipient NPIs · example record 1201352548 |
Lumigan · 2024 Exact normalized brand match · 1 Part D row |
33 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | VRAYLAR open payments reported associated product |
CMS Open Payments — General Payments 377741 supporting records · 62704 recipient NPIs · example record 1201352550 |
Vraylar · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
396 | 43 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
14 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
107 | 11 |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | NUEDEXTA open payments reported associated product |
CMS Open Payments — General Payments 393 supporting records · 285 recipient NPIs · example record 1227268901 |
Nuedexta · 2024 Exact normalized brand match · 1 Part D row |
26 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 4531 | 415 |
| Amlodipine Besylate | Amlodipine Besylate | 2909 | 296 |
| Levothyroxine Sodium | Levothyroxine Sodium | 2887 | 285 |
| Donepezil Hcl | Donepezil Hcl | 2805 | 259 |
| Furosemide | Furosemide | 2632 | 283 |
| Sertraline Hcl | Sertraline Hcl | 2406 | 221 |
| Memantine Hcl | Memantine Hcl | 2319 | 224 |
| Gabapentin | Gabapentin | 2101 | 199 |
| Potassium Chloride | Potassium Chloride | 2081 | 213 |
| Eliquis | Apixaban | 2009 | 180 |
| Pantoprazole Sodium | Pantoprazole Sodium | 1827 | 216 |
| Metoprolol Succinate | Metoprolol Succinate | 1783 | 171 |
| Metoprolol Tartrate | Metoprolol Tartrate | 1695 | 152 |
| Escitalopram Oxalate | Escitalopram Oxalate | 1586 | 145 |
| Lisinopril | Lisinopril | 1564 | 169 |
| Tamsulosin Hcl | Tamsulosin Hcl | 1312 | 121 |
| Omeprazole | Omeprazole | 1309 | 129 |
| Losartan Potassium | Losartan Potassium | 1306 | 144 |
| Mirtazapine | Mirtazapine | 1243 | 133 |
| Carvedilol | Carvedilol | 1128 | 107 |
| Metformin Hcl | Metformin Hcl | 1042 | 111 |
| Quetiapine Fumarate | Quetiapine Fumarate | 982 | 113 |
| Trazodone Hcl | Trazodone Hcl | 946 | 132 |
| Clopidogrel | Clopidogrel Bisulfate | 925 | 99 |
| Spironolactone | Spironolactone | 908 | 87 |
| Famotidine | Famotidine | 905 | 98 |
| Simvastatin | Simvastatin | 689 | 80 |
| Duloxetine Hcl | Duloxetine Hcl | 663 | 61 |
| Hydrochlorothiazide | Hydrochlorothiazide | 594 | 62 |
| Pravastatin Sodium | Pravastatin Sodium | 575 | 54 |
| Allopurinol | Allopurinol | 494 | 47 |
| Levetiracetam | Levetiracetam | 479 | 43 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 479 | 49 |
| Montelukast Sodium | Montelukast Sodium | 459 | 56 |
| Olanzapine | Olanzapine | 456 | 45 |
| Xarelto | Rivaroxaban | 432 | 50 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 416 | 41 |
| Finasteride | Finasteride | 413 | 37 |
| Jardiance | Empagliflozin | 396 | 43 |
| Alendronate Sodium | Alendronate Sodium | 394 | 39 |
| Citalopram Hbr | Citalopram Hydrobromide | 389 | 34 |
| Risperidone | Risperidone | 389 | 45 |
| Buspirone Hcl | Buspirone Hcl | 387 | 33 |
| Divalproex Sodium | Divalproex Sodium | 364 | 40 |
| Glimepiride | Glimepiride | 363 | 40 |
| Januvia | Sitagliptin Phosphate | 363 | 31 |
| Baclofen | Baclofen | 353 | 24 |
| Bumetanide | Bumetanide | 351 | 28 |
| Hydralazine Hcl | Hydralazine Hcl | 345 | 48 |
| Amiodarone Hcl | Amiodarone Hcl | 338 | 34 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 328 | 34 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 315 | 28 |
| Metolazone | Metolazone | 296 | 38 |
| Midodrine Hcl | Midodrine Hcl | 276 | 38 |
| Warfarin Sodium | Warfarin Sodium | 271 | 20 |
| Ondansetron Hcl | Ondansetron Hcl | 268 | 105 |
| Aripiprazole | Aripiprazole | 264 | 30 |
| Ropinirole Hcl | Ropinirole Hcl | 250 | 17 |
| Klor-Con M20 | Potassium Chloride | 248 | 27 |
| Meloxicam | Meloxicam | 247 | 25 |
| Fluoxetine Hcl | Fluoxetine Hcl | 227 | 19 |
| Single Use Swab | Alcohol Antiseptic Pads | 227 | 47 |
| Paroxetine Hcl | Paroxetine Hcl | 226 | 19 |
| Ezetimibe | Ezetimibe | 219 | 19 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 219 | 14 |
| Entresto | Sacubitril/Valsartan | 217 | 29 |
| Torsemide | Torsemide | 210 | 13 |
| Latanoprost | Latanoprost | 209 | 58 |
| Oxybutynin Chloride | Oxybutynin Chloride | 206 | 24 |
| Fluticasone Propionate | Fluticasone Propionate | 202 | 70 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 202 | 46 |
| Glipizide | Glipizide | 201 | 24 |
| Loperamide | Loperamide Hcl | 199 | 128 |
| Prednisone | Prednisone | 197 | 44 |
| Lamotrigine | Lamotrigine | 194 | 25 |
| Propranolol Hcl | Propranolol Hcl | 194 | 17 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 193 | 20 |
| Memantine Hcl Er | Memantine Hcl | 190 | 19 |
| Galantamine Hbr | Galantamine Hbr | 189 | 19 |
| Tradjenta | Linagliptin | 184 | 18 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 179 | 23 |
| Cephalexin | Cephalexin | 171 | 68 |
| Myrbetriq | Mirabegron | 171 | 20 |
| Dicyclomine Hcl | Dicyclomine Hcl | 166 | 19 |
| Primidone | Primidone | 166 | 13 |
| Methenamine Hippurate | Methenamine Hippurate | 162 | 11 |
| Bupropion Xl | Bupropion Hcl | 151 | 19 |
| Atenolol | Atenolol | 149 | 15 |
| Lovastatin | Lovastatin | 149 | 19 |
| Irbesartan | Irbesartan | 144 | 15 |
| Sucralfate | Sucralfate | 137 | 17 |
| Divalproex Sodium Er | Divalproex Sodium | 136 | 14 |
| Metformin Hcl Er | Metformin Hcl | 136 | 17 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 134 | 40 |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 133 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 133 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 133 | 66 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 130 | 20 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 130 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 128 | 15 |
| Digoxin | Digoxin | 123 | 18 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 121 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 120 | suppressed |
| Calcitriol | Calcitriol | 119 | 12 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 117 | 63 |
| Doxycycline Hyclate | Doxycycline Hyclate | 112 | 42 |
| Lansoprazole | Lansoprazole | 110 | suppressed |
| Sotalol | Sotalol Hcl | 110 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 109 | 22 |
| Nystatin | Nystatin | 107 | 61 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 107 | suppressed |
| Trulicity | Dulaglutide | 107 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 102 | 18 |
| Nifedipine Er | Nifedipine | 101 | 16 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 97 | 45 |
| Nebivolol Hcl | Nebivolol Hcl | 96 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 95 | 17 |
| Bupropion Hcl Sr | Bupropion Hcl | 94 | 14 |
| Benazepril Hcl | Benazepril Hcl | 93 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 93 | 23 |
| Breo Ellipta | Fluticasone/Vilanterol | 91 | 21 |
| Valsartan | Valsartan | 90 | 11 |
| Lactulose | Lactulose | 85 | 13 |
| Ibuprofen | Ibuprofen | 84 | 31 |
| Ranolazine Er | Ranolazine | 83 | suppressed |
| Timolol Maleate | Timolol Maleate | 83 | 19 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 81 | 19 |
| Bupropion Hcl | Bupropion Hcl | 80 | 11 |
| Diltiazem Hcl | Diltiazem Hcl | 80 | suppressed |
| Novolog Flexpen | Insulin Aspart | 80 | 14 |
| Daptomycin | Daptomycin | 78 | suppressed |
| Rivastigmine | Rivastigmine | 78 | 15 |
| Humalog Kwikpen U-100 | Insulin Lispro | 77 | 21 |
| Oxcarbazepine | Oxcarbazepine | 77 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 76 | suppressed |
| Cilostazol | Cilostazol | 75 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 74 | 18 |
| Ondansetron Odt | Ondansetron | 74 | 26 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 73 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 73 | 11 |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 72 | 34 |
| Incruse Ellipta | Umeclidinium Bromide | 71 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 70 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 70 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 70 | 32 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 69 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 67 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 67 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 66 | 18 |
| Amitriptyline Hcl | Amitriptyline Hcl | 65 | suppressed |
| Chlorthalidone | Chlorthalidone | 65 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 64 | suppressed |
| Galantamine Er | Galantamine Hbr | 62 | suppressed |
| Jantoven | Warfarin Sodium | 62 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 61 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 59 | 47 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 59 | suppressed |
| Ursodiol | Ursodiol | 59 | suppressed |
| Hydrocortisone | Hydrocortisone | 58 | 12 |
| Carbamazepine Er | Carbamazepine | 57 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 56 | 12 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 56 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 54 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 54 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 54 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 54 | suppressed |
| Nystop | Nystatin | 53 | 28 |
| Pioglitazone Hcl | Pioglitazone Hcl | 53 | suppressed |
| Amantadine | Amantadine Hcl | 52 | suppressed |
| Novolog | Insulin Aspart | 52 | suppressed |
| Topiramate | Topiramate | 52 | suppressed |
| Budesonide Er | Budesonide | 51 | suppressed |
| Cevimeline Hcl | Cevimeline Hcl | 51 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 49 | 18 |
| Meropenem | Meropenem | 48 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 47 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 47 | suppressed |
| Levofloxacin | Levofloxacin | 47 | 27 |
| Lubiprostone | Lubiprostone | 47 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 45 | 11 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 45 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 45 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 44 | 36 |
| Enalapril Maleate | Enalapril Maleate | 44 | suppressed |
| Ozempic | Semaglutide | 43 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 42 | suppressed |
| Budesonide Dr | Budesonide | 40 | suppressed |
| Cefdinir | Cefdinir | 40 | 27 |
| Celecoxib | Celecoxib | 40 | suppressed |
| Fenofibrate | Fenofibrate | 40 | suppressed |
| Anastrozole | Anastrozole | 39 | suppressed |
| Methimazole | Methimazole | 39 | suppressed |
| Restasis | Cyclosporine | 38 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 36 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 35 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 35 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 34 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 34 | 17 |
| Naproxen | Naproxen | 34 | 12 |
| Lumigan | Bimatoprost | 33 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 32 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 32 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 31 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 31 | suppressed |
| Unifine Safecontrol Pen Needle | Pen Needle,dual Safety,diabetc | 31 | 11 |
| Dorzolamide Hcl | Dorzolamide Hcl | 30 | 11 |
| Lithium Carbonate Er | Lithium Carbonate | 30 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 30 | suppressed |
| Acyclovir | Acyclovir | 29 | suppressed |
| Colchicine | Colchicine | 29 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 29 | suppressed |
| Glipizide Er | Glipizide | 29 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 29 | suppressed |
| Folic Acid | Folic Acid | 28 | suppressed |
| Lorazepam | Lorazepam | 28 | 11 |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 26 | suppressed |
| Cholestyramine Light | Cholestyramine | 26 | suppressed |
| Cimetidine | Cimetidine | 26 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 26 | suppressed |
| Dexamethasone | Dexamethasone | 25 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 25 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 24 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 24 | suppressed |
| Levocarnitine | Levocarnitine | 24 | suppressed |
| Methylprednisolone | Methylprednisolone | 24 | suppressed |
| Pentoxifylline | Pentoxifylline | 24 | suppressed |
| Verapamil Er | Verapamil Hcl | 24 | suppressed |
| Acetazolamide | Acetazolamide | 23 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 23 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 23 | 16 |
| Glycopyrrolate | Glycopyrrolate | 23 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 23 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 22 | suppressed |
| Azithromycin | Azithromycin | 22 | 14 |
| Mesalamine | Mesalamine | 22 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 22 | suppressed |
| Nyamyc | Nystatin | 22 | 15 |
| Tizanidine Hcl | Tizanidine Hcl | 22 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 21 | suppressed |
| Fluconazole | Fluconazole | 21 | 13 |
| Gemtesa | Vibegron | 21 | suppressed |
| Humalog | Insulin Lispro | 21 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 21 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 21 | 13 |
| Budesonide Ec | Budesonide | 20 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 20 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 20 | suppressed |
| Ramipril | Ramipril | 20 | suppressed |
| Tacrolimus | Tacrolimus | 20 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 19 | suppressed |
| Linzess | Linaclotide | 19 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 19 | suppressed |
| Insulin Lispro | Insulin Lispro | 18 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 18 | suppressed |
| Travoprost | Travoprost | 18 | suppressed |
| Trimethoprim | Trimethoprim | 18 | suppressed |
| Amoxicillin | Amoxicillin | 17 | 15 |
| Atropine Sulfate | Atropine Sulfate | 17 | 15 |
| Mirabegron Er | Mirabegron | 17 | suppressed |
| Simbrinza | Brinzolamide/Brimonidine Tart | 17 | suppressed |
| Telmisartan | Telmisartan | 17 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 16 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 16 | 11 |
| Prednisolone Acetate | Prednisolone Acetate | 16 | suppressed |
| Synthroid | Levothyroxine Sodium | 16 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 16 | suppressed |
| Bicalutamide | Bicalutamide | 15 | suppressed |
| Cefadroxil | Cefadroxil | 15 | suppressed |
| Creon | Lipase/Protease/Amylase | 15 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 15 | suppressed |
| Indapamide | Indapamide | 15 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 15 | suppressed |
| Repatha Sureclick | Evolocumab | 15 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 15 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 14 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 14 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 14 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 14 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 14 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 14 | suppressed |
| Methocarbamol | Methocarbamol | 14 | suppressed |
| Metronidazole | Metronidazole | 14 | suppressed |
| Mounjaro | Tirzepatide | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | suppressed |
| Serevent Diskus | Salmeterol Xinafoate | 14 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 14 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 14 | suppressed |
| Acamprosate Calcium | Acamprosate Calcium | 13 | suppressed |
| Alprazolam | Alprazolam | 13 | suppressed |
| Darifenacin Er | Darifenacin Hydrobromide | 13 | suppressed |
| Enulose | Lactulose | 13 | suppressed |
| Exelon | Rivastigmine | 13 | suppressed |
| Fingolimod | Fingolimod Hcl | 13 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 13 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 13 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 13 | suppressed |
| Mupirocin | Mupirocin | 13 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 13 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 13 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 13 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 13 | suppressed |
| Vraylar | Cariprazine Hcl | 13 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 12 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 12 | suppressed |
| Brilinta | Ticagrelor | 12 | suppressed |
| Hydroxyurea | Hydroxyurea | 12 | suppressed |
| Paliperidone Er | Paliperidone | 12 | suppressed |
| Phenelzine Sulfate | Phenelzine Sulfate | 12 | suppressed |
| Pimecrolimus | Pimecrolimus | 12 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 12 | suppressed |
| Rhopressa | Netarsudil Mesylate | 12 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 11 | suppressed |
| Clomipramine Hcl | Clomipramine Hcl | 11 | suppressed |
| Erythromycin | Erythromycin Base | 11 | 11 |
| Leflunomide | Leflunomide | 11 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 11 | suppressed |
| Phenytek | Phenytoin Sodium Extended | 11 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 11 | suppressed |
| Pregabalin | Pregabalin | 11 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 11 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 11 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $332.29 · 9 records | Otsuka America Pharmaceutical, Inc. | AMYVID, BOTOX, IQIRVO, KISUNLA, LUMRYZ, QULIPTA, REXULTI | 9 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error